Activity of trypanosome lytic factor: A novel component of innate immunity

Future Microbiology

Volumn 4, Issue 7, 2009, Pages 789-796

  Thomson, Russell ^a   Samanovic, Marie ^a   Raper, Jayne ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

African sleeping sickness; ApoL I; Apolipoprotein L I; Haptoglobin related protein; Hpr; Innateimmunity; Leishmania; Pore forming protein; Serum resistance associated protein; SRA protein; TLF; Trypanosoma ucei; Trypanosome lytic factor

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN L1; COLICIN; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; TRYPANOSOME LYTIC FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CHLORIDE TRANSPORT; GENE DUPLICATION; GENE LOCUS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LYSIS; MOLECULAR MECHANICS; MULTIGENE FAMILY; NONHUMAN; PARALOGY; PARASITE IMMUNITY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRYPANOSOMA BRUCEI; TRYPANOSOMA RHODESIENSE; TRYPANOSOMIASIS;

ANIMALS; HUMANS; IMMUNITY, INNATE; LEISHMANIA; LIPOPROTEINS, HDL; PRIMATES; TRYPANOSOMA;

PRIMATES; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 70349217237     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.57     Document Type: Article

References (71)

1. Gibson WC: The SRA gene: the key to understanding the nature of Trypanosoma brucei rhodesiense. Parasitology 131, 143-150 (2005).
2. Raper J, Portela Molina MP, Redpath M, Tomlinson S, Lugli E, Green H: Natural immunity to human African trypanosomiasis: trypanosome lytic factors and the blood incubation infectivity test. Trans. R. Soc. Trop. Med. Hyg. 96(Suppl. 1), S145-S150 (2002).
3. Fevre EM, Picozzi K, Janmin J, Welburn SC, Maudlin I: Human African trypanosomiasis: epidemiology and control. Adv. Parasitol. 6, 167-222 (2006).
4. Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S: Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910-1916 (1999).
5. Lugli EB, Pouliot M, Portela Mdel P, Loomis MR, Raper J: Characterization of primate trypanosome lytic factors. Mol. Biochem. Parasitol. 138, 9-20 (2004).
6. Smith AB, Esko JD, Hajduk SL: Killing of trypanosomes by the human haptoglobin-related protein. Science 268, 284-286 (1995).
7. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P et al.: Apolipbprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83-87 (2003).
8. Vanhollebeke B, Pays E. The function of apolipoproteins L. Cell Mol. Life Sci. 63, 1937-1944 (2006).
9. Smith EE, Malik HS: The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. Genome Res. 19, 850-858 (2009).
10. Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJ: The apolipoprotein-L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79, 539-546 (2002).
11. Liu Z, Lu H, Jiang Z, Pastuszyn A, Hu CA: Apolipoprotein L6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol. Cancer Res. 3, 21-31 (2005).
12. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA: Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J. Biol. Chem. 283, 21540-21549 (2008).
13. Poelvoorde P, Vanhamme L, Van Den Abbeele J, Switzer WM, Pays E: Distribution of apolipoprotein L-1 and trypanosome lytic activity among primate sera. Mol. Biochem. Parasitol. 134, 155-157 (2004).
14. Thomson R, Molina Portela MP, Raper J: Identification and cloning of baboon TLE which kills human infective African trypanosomes in vivo. Am. J. Trop. Med. Hyg. 79, 350-390 (2008).
15. McEvoy SM, Maeda N: Complex events in the evolution of the haptoglobin gene cluster in primates. J. Biol. Chem. 263, 15740-15747 (1988).
16. Hatada S, Grant DJ, Maeda N: An intronic endogenous retrovirus-like sequence attenuates human haptoglobin-related gene expression in an orientation-dependent manner. Gene 319, 55-63 (2003).
17. Kristiansen M, Graversen JH, Jacobsen C et al.: Identification of the haemoglobin scavenger receptor. Nature 409, 198-201 (2001).
18. Nielsen MJ, Petersen SV, Jacobsen C et al.: Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein. Blood 108, 2846-2849 (2006).
19. Quaye IK: Haptoglobin, inflammation and disease. Trans. R. Soc. Trop. Med. Hyg. 102, 735-742 (2008).
20. Nielsen MJ, Petersen SV, Jacobsen C et al.: A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J. Biol. Chem. 282, 1072-1079 (2007).
21. Shiflett AM, Bishop JR, Pahwa A, Hajduk SL: Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J. Biol. Chem. 280, 32578-32585 (2005).
22. Oli MW, Cotlin LF, Shiflett AM, Hajduk SL: Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei. Eukaryot. Cell 5, 132-139 (2006).
23. Green HP, Del Pilar Molina Portela M, St Jean EN, Lugli EB, Raper J: Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J. Biol. Chem. 278, 422-427 (2003).
24. Drain J, Bishop JR, Hajduk SL: Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 276, 30254-30260 (2001).
25. Vanhollebeke B, De Muylder G, Nielsen MJ et al.: A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320, 677-681 (2008).
26. Molina-Portela MP, Samanovic M, Raper J: Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J. Exp. Med. 205, 1721-1728 (2008).
27. Vanhollebeke B, Nielsen MJ, Watanabe T et al.: Distinct roles of haptoglobin-related protein and apolipoprotein L-1 in trypanolysis by human serum. Proc. Natl Acad. Sci. USA 104, 4118-4123 (2007).
28. Shimamura M, Hager KM, Hajduk SL: The lysosomal targeting and intracellular metabolism of trypanosome lytic factor by Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 115, 227-237 (2001).
29. Raper J, Portela MP, Lugli E, Frevert U, Tomlinson S: Trypanosome lytic factors: novel mediators of human innate immunity. Curr. Opin. Microbiol. 4, 402-408 (2001).
30. Molina-Portela Mdel P, Lugli EB, Recio-Pinto E, Raper J: Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes. Mol. Biochem. Parasitol. 144, 218-226 (2005).
31. Harrington JM, Howell S, Hajduk SL: Membrane permeabilization by trypanosome lytic factor, a cytolytic human high-density lipoprotein. J. Biol. Chem. 284, 13505-13512 (2009).
32. Bishop JR, Shimamura M, Hajduk SL: Insight into the mechanism of trypanosome lytic factor-1 killing of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 118, 33-40 (2001).
33. Widener J, Nielsen MJ, Shiflett A, Moestrup S, Hajduk S: Hemoglobin is a co-factor of human trypanosome lytic factor. PLoS Pathog. 3, e129 (2007).
34. Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F et al.: Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469-472 (2005).
35. Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Perez-Morga D: The trypanolytic factor of human serum. Nat. Rev. Microbiol. 4, 477-486 (2006).
36. Field MC, Carrington M: Intracellular membrane transport systems in Trypanosoma brucei. Traffic 5, 905-913 (2004).
37. Engstler M, Pfohl T, Herminghaus S et al.: Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 131, 505-515 (2007).
38. Engstler M, Thilo L, Weise F et al.: Kinetics of endocytosis and recycling of the GPI- anchored variant surface glycoprotein in Trypanosoma brucei. J. Cell Sci. 117, 1105-1115 (2004).
39. Molina Portela MP, Raper J, Tomlinson S: An investigation into the mechanism of trypanoqome lysis by human serum factors. Mol. Biochem. Parasitol. 110, 273-282 (2000).
40. Raper J, Nussenzweig Y, Tomlinson S: The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J. Exp. Med. 183, 1023-1029 (1996).
41. Muranjan M, Nussenzweig V, Tomlinson S: Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J. Biol. Chem. 273, 3884-3887 (1998).
42. Simarro PP, Jannin J, Cattand P: Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med. 5, e55 (2008).
43. De Greef C, Chimfwembe E, Kihang'a Wabacha J, Bajyana Songa E, Hamers R: Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein. Ann. Soc. Belg. Med. Trop. 72(Suppl. 1), 13-21 (1992).
44. Xong HV, Vanhamme L, Chamekh M et al.: A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839-846 (1998).
45. Radwanska M, Chamekh M, Vanhamme L et al.: The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am. J. Trop. Med. Hyg. 67, 684-690 (2002).
46. Campillo N, Carrington M: The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 127, 79-84 (2003).
47. Baral TN, Magez S, Stijlemans B et al.: Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat. Med. 12, 580-584 (2006).
48. Lins L, Decaffmeyer M, Thomas A, Brasseur R: Relationships between the orientation and the structural properties of peptides and their membrane interactions. Biochim. Biophys. Acta 1778, 1537-1544 (2008).
49. Peters NC, Egen JG, Secundino N et al.: In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321, 970-974 (2008).
50. Courret N, Frehel C, Gouhier N et al.: Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. J Cell Sci. 115, 2303-2316 (2002).
51. Despommier D, Gwadz W, Hotez P, Knirsch A: Introduction to the Leishmania. In: Parasitic Diseases (5th Edition). Apple Trees Productions LLC, NY, USA, 13-17 (2005).
52. Samanovic M, Molina-Portela MP, Chessler AD, Burleigh BA, Raper J: Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog. 5, e1000276 (2009).
53. Krieger M: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J. Clin. Invest. 108, 793-797 (2001).
54. Eckhardt ER, Cai L, Sun B, Webb NR, van der Westhuyzen DR: High density lipoprotein uptake by scavenger receptor SR-BII. J. Biol. Chem. 279, 14372-14381 (2004).
55. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA: Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39, 777-788 (1998).
56. El Ghmati SM, Van Hoeyveld EM, Van Strijp JG, Ceuppens JL, Stevens EA: Identification of haptoglobin as an alternative ligand for CD11b/CD18. J. Immunol. 156, 2542-2552 (1996).
57. Pays F, Vanhollebeke B: Mutual self-defence: the trypanolytic factor story. Microbes Infect. 12, 12 (2008).
58. Veras PS, de Chastellier C, Moreau MF et al.: Fusion between large phagocytic vesicles: targeting of yeast and other particulates to phagolysosomes that shelter the bacterium Coxialla burnetii or the protozoan Leishmania amazonensis in Chinese hamster ovary cells. J. Cell Sci. 107(Pt 11), 3065-3076 (1994).
59. Vergne I, Chua J, Singh SB, Deretic V: Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20. 367-394 (2004).
60. Eissenberg LG, Goldman WE, Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J. Exp. Med. 177, 1605-1611 (1993).
61. Newman SL, Gootee L, Hilty J, Morris RE: Human macrophages do not require phagosonme acidification to mediate fungistatic/fungicidal activity against Histoplasma capsulatum. J. Immunol. 176, 1806-1813 (2006).
62. Holden DW: Trafficking of the Salmonella vacuole in macrophages. Traffic 3, 161-169 (2002).
63. Alvarez M, Casadevall A: Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16, 2161-2165 (2006).
64. Amer AO, Swanson MS: A phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5, 56-61 (2002).
65. Paetzold S, Lourido S, Raupach B, Zychlinsky A: Shigella flexneri phagosomal escape is independent of invasion. Infect. Immun. 75, 4826-4830 (2007).
66. Mott GA, Burleigh BA: The role of host cell lysosomes in Trypanosoma cruzi invasion. Subcell. Biochem. 47, 165-173 (2008).
67. Charron AJ, Sibley LD: Molecular partitioning during host cell penetration by Toxoplasma gondii. Traffic 5, 855-867 (2004).
68. Coppens I, Dunn JD, Romano JD et al.: Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 125, 261-274 (2006).
69. Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, Gorvel JP: Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198, 545-556 (2003).
70. Vanhollebeke B, Truc P, Poelvoorde P et al.: Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N. Engl. J. Med. 355, 2752-2756 (2006).
71. Bucheton B, Abel L, El-Safi S et al.: A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am. J. Hum. Genet. 73, 1052-1060 (2003).